X
TMO icon

Xponance’s Thermo Fisher Scientific TMO Stock Holding History

Xponance’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5M Buy
68,808
+684
+1% +$328K 0.21% 69
2026
Q1 		$33.5M Buy
68,124
+8,829
+15% +$4.79M 0.24% 68
2025
Q4 		$34.4M Buy
59,295
+4,436
+8% +$2.51M 0.26% 62
2025
Q3 		$26.6M Sell
54,859
-3,464
-6% -$1.61M 0.21% 75
2025
Q2 		$23.6M Buy
58,323
+1,550
+3% +$648K 0.2% 81
2025
Q1 		$28.3M Buy
56,773
+35
+0.1% +$19K 0.27% 55
2024
Q4 		$29.5M Buy
56,738
+149
+0.3% +$81.9K 0.27% 53
2024
Q3 		$35M Buy
56,589
+881
+2% +$522K 0.34% 38
2024
Q2 		$30.8M Sell
55,708
-23,200
-29% -$13.3M 0.31% 43
2024
Q1 		$45.9M Buy
78,908
+2,147
+3% +$1.2M 0.48% 31
2023
Q4 		$40.7M Buy
76,761
+3,487
+5% +$1.69M 0.49% 30
2023
Q3 		$37.1M Sell
73,274
-981
-1% -$523K 0.5% 29
2023
Q2 		$38.7M Buy
74,255
+20,241
+37% +$10.9M 0.52% 29
2023
Q1 		$31.1M Buy
54,014
+1,285
+2% +$724K 0.46% 34
2022
Q4 		$29M Buy
52,729
+7,770
+17% +$4.12M 0.47% 32
2022
Q3 		$22.8M Buy
44,959
+3,432
+8% +$1.92M 0.44% 34
2022
Q2 		$22.6M Sell
41,527
-1,697
-4% -$934K 0.45% 34
2022
Q1 		$25.5M Buy
43,224
+503
+1% +$289K 0.42% 38
2021
Q4 		$28.5M Buy
42,721
+11,275
+36% +$7.04M 0.45% 35
2021
Q3 		$18M Sell
31,446
-1,981
-6% -$1.09M 0.34% 55
2021
Q2 		$16.9M Sell
33,427
-18,329
-35% -$8.65M 0.31% 65
2021
Q1 		$23.6M Sell
51,756
-217
-0.4% -$104K 0.5% 36
2020
Q4 		$24.2M Buy
51,973
+637
+1% +$299K 0.53% 34
2020
Q3 		$22.7M Sell
51,336
-2,405
-4% -$994K 0.56% 30
2020
Q2 		$19.5M Buy
+53,741
New +$18M 0.5% 32

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Xponance's TMO Position: Q2 2026 in Review

Xponance increased its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, buying an estimated $328K and bringing the position to 68,808 shares worth $34.5M. The position accounts for 0.21% of the portfolio, ranked #69.

Xponance first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $45.9M in Q1 2024. 2,603 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Xponance held 68,808 shares of Thermo Fisher Scientific worth $34.5M as of Q2 2026.
  • Xponance bought 684 Thermo Fisher Scientific shares in Q2 2026, an estimated $328K.
  • Thermo Fisher Scientific made up 0.21% of Xponance's portfolio in Q2 2026, its #69 holding.
  • Xponance first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Thermo Fisher Scientific position peaked at $45.9M in Q1 2024.
  • 2,603 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.